Skip to main content

Physician Dispensed Cosmeceuticals Market to Surpass 16.7 Billion by 2030 Drives Due to the Medical Expertise Synergy

SkyQuest projects that the physician-dispensed cosmeceuticals market will attain a USD 16.7 billion value by 2030, with a CAGR of 7.8% over the forecast period (2023-2030). The physician-dispensed cosmeceuticals market is experiencing a notable surge, spurred by evolving consumer preferences favoring healthful and nourishing dietary choices, particularly in response to the escalating concerns surrounding obesity and the ageing demographic. The heightened awareness of the importance of a balanced diet has increased demand for dried fruit, recognized for its inherent nutritional value.

Westford, USA, Aug. 17, 2023 (GLOBE NEWSWIRE) — According to SkyQuest, Physician dispensed cosmeceuticals offer clinical-grade formulations that undergo rigorous testing and quality control. These products contain potent ingredients at higher concentrations, visibly improving skin health and appearance. Consumers are drawn to the promise of professional-grade solutions that address specific concerns.

Browse in-depth TOC on the “Physician Dispensed Cosmeceuticals Market”

  • Pages – 157
  • Tables – 64
  • Figures – 68

Get sample copy of this report:

https://www.skyquestt.com/sample-request/physician-dispensed-cosmeceuticals-market

Physicians provide credibility and accountability to the cosmeceutical market. Consumers trust medical professionals for skincare guidance, relying on their expertise to make informed decisions. Physician dispensed products inspire confidence through professional recommendation, ensuring clients receive genuine, beneficial products amidst the saturated skincare landscape.

 Prominent Players in the Physician Dispensed Cosmeceuticals Market

  • Allergan Plc
  • SkinMedica, Inc.
  • Biopelle, Inc.
  • Clinique Laboratories, LLC
  • Cutera, Inc.
  • Emerson Ecologics, LLC
  • iS CLINICAL
  • Jan Marini Skin Research, Inc.
  • La Roche-Posay Laboratoire Pharmaceutique
  • Neutrogena Corp.
  • Obagi Medical Products, Inc.
  • SkinCeuticals
  • Stiefel Laboratories, Inc.

Browse summary of the report and Complete Table of Contents (ToC):

https://www.skyquestt.com/report/physician-dispensed-cosmeceuticals-market

Eye Care Segment is Expected to Grow the Market Due to their Increasing Awareness of the Delicate and Unique Needs of the Eye Area

The eye care segment is rapidly growing in the physician-dispensed cosmeceuticals market. With increasing awareness of the delicate and unique needs of the eye area, consumers are turning to medical professionals for specialized solutions. Physician-dispensed eye care cosmeceuticals offer targeted formulations to address concerns like dark circles, puffiness, and fine lines.

North America emerges as a dominant region in the physician-dispensed cosmeceuticals market. The robust presence of advanced healthcare infrastructure, well-established dermatological practices, and a proactive consumer base drives the region’s prominence. High disposable incomes enable consumers to invest in premium skincare solutions medical professionals recommend.

Skin Care is Expected to Dominate the Market Due to its Wide Array of Products Addressing

The skincare segment is the dominant force in the physician-dispensed cosmeceuticals market. Focusing on targeted solutions, it encompasses various products addressing diverse skin concerns such as ageing, hyperpigmentation, and acne. The medical endorsement bolsters credibility, driving consumer trust in these clinically formulated products. Customized treatments tailored by physicians further accentuate the segment’s prominence, catering to individual skin needs.

Regional markets in the Asia-Pacific (APAC) region emerge as a swiftly expanding market for physician-dispensed cosmeceuticals. Driven by a confluence of factors such as a growing middle-class population, increasing disposable income, and a strong emphasis on skin care routines, APAC’s demand for advanced skincare solutions is on the rise. The region’s cultural emphasis on youthful appearance and flawless skin further propels the adoption of physician-endorsed products.

A comprehensive analysis of the major players in the physician dispensed cosmeceuticals market has been recently conducted in a report. The report encompasses various aspects, including collaborations, mergers, innovative business policies, and strategies, providing valuable insights into key trends and breakthroughs in the market. Furthermore, the report scrutinizes the market share of the top segments and presents a detailed geographic analysis. Lastly, the report highlights the major players in the industry and their endeavors to develop innovative solutions to cater to the growing demand.

Key Developments in the Physician Dispensed Cosmeceuticals Market

  • In May 2022, Xilica and Sennheiser expanded their collaboration with the introduction of two new pre-validated, plug-and-play “room kits” for medium and large collaboration spaces. The IT-compliant room kits combine premium PoE-powered Xilica and Sennheiser audio conferencing solutions in a single compact in-ceiling system, with all components connected via CatX network cable.
  • In June 2022, Nureva announced the appointment of AV Supply Group as its Australian distributor. Nureva’s audio conferencing products were first introduced to the New Zealand market in 2017, and the group’s expansion into Australia recognizes the demand from the shift to hybrid working and learning models.

Speak to Analyst for your custom requirements:

https://www.skyquestt.com/speak-with-analyst/physician-dispensed-cosmeceuticals-market

Key Questions Answered in Physician Dispensed Cosmeceuticals Market Report

  • What specific growth drivers are projected to impact the market during the forecast period?
  • List the top companies in the market and explain how they have achieved their positions of influence.
  • In what ways do regional trends and patterns differ within the global market, and how these differences shape the market’s future growth?

Related Reports in SkyQuest’s Library:

Global Biotechnology & Pharmaceutical Services Outsourcing Market

Global Shingles Vaccine Market

Global Bovine Lactoferrin Market 

Global Pharmaceutical Manufacturing Market

Global Immune Health Supplements Market

About Us:

SkyQuest Technology is leading growth consulting firm providing market intelligence, commercialization and technology services. It has 450+ happy clients globally.

Address:

1 Apache Way, Westford, Massachusetts 01886

Phone:

USA (+1) 617-230-0741

Email: sales@skyquestt.com

LinkedIn Facebook Twitter

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.